Yükleniyor... / Loading...
This study is part of the GENE-FORECAST program and assessed how sodium intake affects cardiovascular health in African American individuals, using sodium chloride and placebo (an inactive substance). Former GENE-FORECAST participants aged 21-65 with normal blood pressure could take part. This study without an assigned phase has been carried out and is completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
* INCLUSION CRITERIA: African American men and women who are former GENE-FORECAST participants between 21 and 65 years of age. This criterion is inclusive of self-identified AA of both Hispanic, Latino and non-Hispanic, Latino ethnicities. Normotensive participants with systolic blood pressure (SBP) \<140 mm Hg and diastolic blood pressure (DBP) \<90 mm Hg and the absence of a history of prior diagnosis of hypertension. -Willingness and ability to participate in study procedures. EXCLUSION CRITERIA: * Individuals who are pregnant or breast-feeding. * Individuals with high blood pressure or a history of hypertension. * Individuals with a history of myocardial infarction, stroke, heart failure, diabetes, chronic liver or kidney diseases. * Individuals who are taking antihypertensive, antidepressants, antidiabetic and antibiotic medications. * Individuals currently participating in another NIH protocol. * Individuals unable to provide informed consent.